Board of Directors

Peter (Peizhi) Luo, Ph.D.

Peter (Peizhi) Luo, Ph.D.

Co-Founder, CEO, and Chairman of the Board, Adagene

Peter (Peizhi) Luo, Ph.D., co-founder and Chief Executive Officer of Adagene, is an experienced entrepreneur passionate about devising a sustainable biotechnology business strategy by leveraging the industry’s most advanced technology and intellectual property for novel product development. Dr. Luo has focused on studying the fundamental mechanisms of protein folding and design principle, and particularly by computational and experimental approaches for the last 20 years.

Prior to founding Adagene, Dr. Luo was the co-founder, Chief Technology Officer, President and Director of Abmaxis Inc, which was acquired by Merck & Co. in 2006. Dr. Luo then served as Director of Biologics Technology at Merck. Prior to Abmaxis, Dr. Luo served as the first lead scientist in computational protein design and protein laboratory at Xencor.

Dr. Luo completed his postdoctoral research in protein folding with Dr. Robert L. Baldwin at Stanford University. He received his Ph.D. in chemistry under the guidance of Dr. David G. Lynn at The University of Chicago, M.S. in applied physics from The Institute of High Energy Physics of the Chinese Academy of Sciences, and B.S. in applied chemistry from Peking University.

Back to Board of Directors